Effect of Lung Recruitment and Titrated Positive End-Expiratory Pressure (PEEP) vs Low PEEP on Mortality in Patients With Acute Respiratory Distress Syndrome: A Randomized Clinical Trial
Source: View publication →
In patients with moderate to severe ARDS, an aggressive lung recruitment strategy paired with decremental PEEP titration significantly increased 28-day mortality and barotrauma compared to a standard low-PEEP strategy.
Key Findings
Study Design
Study Limitations
Clinical Significance
The ART trial caused a paradigm shift by providing definitive evidence against the routine use of aggressive 'open lung' recruitment maneuvers and best-compliance decremental PEEP titration for patients with moderate-to-severe ARDS. By demonstrating that this intervention paradoxically increases 28-day mortality, barotrauma, and hemodynamic compromise, the trial successfully curbed the growing enthusiasm for aggressive high-pressure recruitment strategies and firmly reinforced the safety and continued use of standard ARDSNet low tidal volume and low-PEEP ventilation protocols.
Historical Context
Following the landmark ARMA trial (2000) that established 6 mL/kg ideal body weight low tidal volume ventilation as the standard of care, subsequent major trials (ALVEOLI, LOVS, EXPRESS) evaluated whether higher PEEP could further improve outcomes. While these studies did not show an overall mortality benefit, subset analyses and meta-analyses suggested potential gains in moderate-to-severe ARDS. This fueled the popularity of the 'open lung approach'—the use of aggressive recruitment maneuvers and high PEEP to avoid cyclic atelectasis (atelectrauma). The ART trial was designed to rigorously test this practice but delivered a surprisingly negative result, demonstrating that the theoretical physiologic benefits of opening the lung are heavily outweighed by the harms of barotrauma and right ventricular/hemodynamic strain.
Guided Discussion
High-yield insights from every perspective
What is the physiological rationale for using Positive End-Expiratory Pressure (PEEP) in ARDS, and what underlying mechanism explains the increased barotrauma seen with aggressive recruitment in the ART trial?
Key Response
ARDS is characterized by alveolar collapse, pulmonary edema, and decreased lung compliance. PEEP is used to prevent cyclical opening and closing of alveoli (atelectrauma) and to improve V/Q matching. However, ARDS is a heterogeneous disease. Aggressive recruitment maneuvers expose the entire lung to very high airway pressures. While this may open collapsed dependent alveoli, it simultaneously causes severe overdistension of relatively normal, non-dependent alveoli, leading to mechanical rupture (barotrauma, such as pneumothorax or pneumomediastinum).
Based on the ART trial findings and standard ARDSNet protocols, how should a resident approach setting PEEP in a newly intubated patient with moderate to severe ARDS?
Key Response
The ART trial demonstrated that an aggressive strategy using maximal recruitment maneuvers and decremental PEEP titration actually increased 28-day mortality and barotrauma compared to a low-PEEP strategy. Therefore, residents should avoid routine use of high-pressure recruitment maneuvers and aggressively high PEEP. Instead, management should focus on standard ARDSNet low tidal volume ventilation (4-6 mL/kg ideal body weight) and using standard PEEP/FiO2 tables to optimize oxygenation while strictly limiting plateau and driving pressures to minimize ventilator-induced lung injury (VILI).
The ART trial demonstrated not only increased barotrauma but also adverse early hemodynamic events during recruitment maneuvers. What are the specific cardiopulmonary interactions occurring during a sustained high-pressure recruitment maneuver, particularly regarding right ventricular (RV) function?
Key Response
Sustained high intrathoracic pressures (e.g., 35-45 cm H2O) drastically alter cardiopulmonary hemodynamics. The elevated alveolar pressure compresses pulmonary capillaries, significantly increasing pulmonary vascular resistance and RV afterload. Concurrently, the high intrathoracic pressure impedes systemic venous return, decreasing RV preload. This combination can precipitate acute RV dilation, septal bowing, and acute cor pulmonale, leading to decreased left ventricular preload and severe systemic hypotension, which likely contributed to the early mortality observed in the ART experimental arm.
How does the ART trial challenge the historical critical care paradigm that 'improving oxygenation equates to improving survival', and how do you incorporate this into your teaching of ICU trainees?
Key Response
For decades, ICU interventions aimed at normalizing physiological variables like PaO2. The ART trial is a classic example of a 'physiologic fallacy' where an intervention (recruitment maneuvers) that might transiently improve oxygenation or lung mechanics actually worsens patient-centered outcomes (survival) due to hidden harms like VILI and hemodynamic collapse. It provides a crucial teaching point for trainees: achieving a surrogate physiologic endpoint is not a substitute for true clinical efficacy, and 'more is not always better' when it comes to positive pressure ventilation.
Scholarly Review
Critical appraisal through the lens of expert reviewers and guideline development
The ART trial was stopped early by the Data and Safety Monitoring Board (DSMB) due to increased mortality in the intervention group. What are the statistical and methodological implications of stopping a trial early for harm, and how does this impact the point estimates and confidence intervals of the primary outcome?
Key Response
Stopping early for harm limits the ultimate sample size and truncates data collection. Statistically, this can reduce the precision of the estimated effect size (wider confidence intervals) and may cause an overestimation of the treatment effect magnitude due to random high bias at the time of the interim analysis. However, ethical imperatives mandate stopping when harm is clear. Methodologists must evaluate whether the pre-specified stopping boundaries (e.g., O'Brien-Fleming) were appropriately stringent and how the early termination affects the power of planned subgroup analyses and subsequent meta-analyses.
During the trial, the protocol for the recruitment maneuver was modified (lowering maximum pressure from 45 to 35 cm H2O) after three cases of cardiac arrest occurred. As a critical appraiser, how do you weigh the impact of an intra-trial protocol change on the study's internal validity and the final interpretation of the intervention's safety?
Key Response
Intra-trial modifications to an intervention, especially safety-driven ones that reduce the exposure dose, introduce heterogeneity into the experimental arm and can threaten internal validity by essentially creating two different intervention groups. A critical reviewer would flag this as potentially diluting the intervention's intended effect. However, editorially, because the trial still found significant harm despite the attenuated intervention, it paradoxically strengthens the conclusion that the aggressive strategy is fundamentally unsafe. The editor must ensure the authors transparently report the timeline of events and analyze the outcomes before and after the protocol amendment.
How should the results of the ART trial influence current ATS/ESICM/SCCM guideline recommendations regarding the routine use of recruitment maneuvers in moderate-to-severe ARDS, and how does this contrast with historical guidelines?
Key Response
Historical guidelines gave conditional recommendations supporting higher PEEP and recruitment maneuvers in severe ARDS based on meta-analyses of older trials (e.g., ALVEOLI, LOVS). The ART trial, demonstrating definitive harm (increased mortality and barotrauma), forced a paradigm shift. Current ATS/ESICM clinical practice guidelines now strongly recommend against the routine use of prolonged high-pressure recruitment maneuvers. The committee must weigh the strong, high-quality evidence of harm from ART against older physiological data, resulting in a downgraded recommendation for aggressive lung recruitment in modern ARDS management algorithms.
Clinical Landscape
Noteworthy Related Trials
ALVEOLI Trial
Tested
Higher PEEP strategy
Population
Patients with acute lung injury and ARDS
Comparator
Lower PEEP strategy
Endpoint
In-hospital mortality
LOVS Trial
Tested
Lung open ventilation strategy including recruitment maneuvers and higher PEEP
Population
Adults with established ARDS
Comparator
Standard ventilation strategy with lower PEEP
Endpoint
All-cause hospital mortality
EXPRESS Trial
Tested
Higher PEEP adjusted to reach plateau pressure of 28 to 30 cm H2O
Population
Patients with ARDS
Comparator
Moderate PEEP of 5 to 9 cm H2O
Endpoint
28-day mortality
Tailored to your role
Want this tailored to you?
Add your specialty or training stage to get role-specific takeaways and more questions.
Personalize this analysis